Leukemia is a cancer of the white blood cells that spreads throughout the bloodstream and may affect many organs. It originates in the bone marrow (spongy center of bones), which is where all blood cells are developed before being released into the bloodstream. Leukemia is classified based on the type of abnormal white blood cell and by how rapidly these cells leave the bone marrow and enter the bloodstream. Acute myeloid leukemia (AML) is the most common type of leukemia that affects adults. The June 10, 2009, issue of JAMA contains an article on allogeneic (from a healthy donor other than an identical twin) stem cell transplantation as a treatment for AML.
Excessive fatigue
Fevers with night sweats
Recurrent infections
Swollen or bleeding gums
Loss of appetite
Enlarged liver or spleen
Easy bruising
Bone or joint pain
Complete medical history and physical examination
Blood tests
Bone marrow aspiration and biopsy (taken with a needle, usually from the hip)
Chest x-ray
Echocardiogram (ultrasound) of the heart
Grahic Jump Location
Determined by:
The age of the patient and differs for those younger than 60 compared to those older than 60
Whether they have received prior chemotherapy
Whether they have other medical problems
Treatment is carried out in 2 phases:
Induction uses chemotherapy to induce remission (normal-appearing blood and bone marrow)
Consolidation therapy is used to achieve a long-lasting remission. The type of treatment offered in this phase depends on the response to the treatment used in the induction phase.
Consolidation therapy options include:
High-dose chemotherapy
Stem cell transplant from the patient himself or herself in remission (autologous ) or from an identical twin (syngenic)
Allogeneic stem cell transplant
Investigational (within a clinical trial) therapy
Centers for Disease Control and Preventionhttp://www.cdc.gov/nceh/radiation/phase2/mleukemi.pdf
National Cancer Institutehttp://www.cancer.gov/cancertopics/pdq/treatment/adultAML/patient
To find this and other JAMA Patient pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on acute lymphoblastic leukemia was published in the January 28, 2009, issue and one on cancer clinical trials was published in the June 9, 2004, issue.
Sources: Centers for Disease Control and Prevention, National Cancer Institute
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: BLOOD DISEASES
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature Although statistical simulation can readily demonstrate how truncated RCTs will overestimate...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.